Literature DB >> 12243742

Brugia malayi: effects of antibacterial agents on larval viability and development in vitro.

Ramakrishna U Rao1, Hanaa Moussa, Gary J Weil.   

Abstract

Recent studies have suggested that intracellular Wolbachia bacteria are necessary for reproduction and survival of adult filarial worms. We now report results of in vitro studies of effects of antibacterial antibiotics (tetracycline, rifampicin, chloramphenicol, azithromycin, and doxycycline) on Brugia malayi infective larvae (L3) motility and molting. All of the antibiotics tested except chloramphenicol decreased L3 motility by 50% or more at 10 days, with minimal effective concentrations (MECs) of 20-100 microg/ml. Tetracyclines, rifampicin, and chloramphenicol inhibited L3 to L4 molting by 12 days in a concentration- and time-dependent manner, with MECs in the range of 1-20 microg/ml. These studies show that antibiotics active against Rickettsiaceae inhibit B. malayi L3 molting at low concentrations in vitro; higher concentrations kill the larvae. While it is possible that antibiotics directly affect filarial L3, we believe it is more likely that the effects seen are indirect effects related to bacterial killing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12243742     DOI: 10.1016/s0014-4894(02)00019-x

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  18 in total

1.  Widespread prevalence of wolbachia in laboratory stocks and the implications for Drosophila research.

Authors:  Michael E Clark; Cort L Anderson; Jessica Cande; Timothy L Karr
Journal:  Genetics       Date:  2005-06-03       Impact factor: 4.562

Review 2.  Gene Transfer Agents in Symbiotic Microbes.

Authors:  Steen Christensen; Laura R Serbus
Journal:  Results Probl Cell Differ       Date:  2020

Review 3.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Effects of gamma radiation on Brugia malayi infective larvae and their intracellular Wolbachia bacteria.

Authors:  R Rao; H Moussa; R P Vanderwaal; E Sampson; L J Atkinson; G J Weil
Journal:  Parasitol Res       Date:  2005-07-05       Impact factor: 2.289

Review 5.  The genome of Brugia malayi - all worms are not created equal.

Authors:  Alan L Scott; Elodie Ghedin
Journal:  Parasitol Int       Date:  2008-09-24       Impact factor: 2.230

6.  Removal of Wolbachia from Brugia pahangi is closely linked to worm death and fecundity but does not result in altered lymphatic lesion formation in Mongolian gerbils (Meriones unguiculatus).

Authors:  Sharon R Chirgwin; Sharon U Coleman; Kristina H Porthouse; Jena M Nowling; George A Punkosdy; Thomas R Klei
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

7.  A review of the complexity of biology of lymphatic filarial parasites.

Authors:  K P Paily; S L Hoti; P K Das
Journal:  J Parasit Dis       Date:  2010-02-27

8.  Effects of doxycycline on gene expression in Wolbachia and Brugia malayi adult female worms in vivo.

Authors:  Ramakrishna U Rao; Yuefang Huang; Sahar Abubucker; Michael Heinz; Seth D Crosby; Makedonka Mitreva; Gary J Weil
Journal:  J Biomed Sci       Date:  2012-02-09       Impact factor: 8.410

9.  Transcriptomes and pathways associated with infectivity, survival and immunogenicity in Brugia malayi L3.

Authors:  Ben-Wen Li; Amy C Rush; Makedonka Mitreva; Yong Yin; David Spiro; Elodie Ghedin; Gary J Weil
Journal:  BMC Genomics       Date:  2009-06-15       Impact factor: 3.969

10.  Localization of Wolbachia-like gene transcripts and peptides in adult Onchocerca flexuosa worms indicates tissue specific expression.

Authors:  Samantha N McNulty; Kerstin Fischer; Kurt C Curtis; Gary J Weil; Norbert W Brattig; Peter U Fischer
Journal:  Parasit Vectors       Date:  2013-01-02       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.